Medicare Compliance & Reimbursement
Industry Notes:
FDA Issues Warning on Misbranded Drugs, Products
Published on Tue Apr 19, 2022
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
- Simple explanations of current healthcare regulations and payer programs
- Real-world reporting scenarios solved by our expert coders
- Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
- Instant access to every article ever published in Revenue Cycle Insider
- 6 annual AAPC-approved CEUs
- The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
Other Articles in this issue of
Medicare Compliance & Reimbursement
- COVID-19 Round-Up:
Put These 3 Updates on Your COVID Checklist
Watch out: Deadlines for PRF reporting are fast approaching. As the pandemic ebbs and flow, [...] - Principal Care Management:
Boost PCM Smarts With This Handy Primer
Ensure PCM billing compliance with a thorough knowledge of current CPT® guidelines. Whether you’ve already [...] - Risk Adjustment:
Find Out the Facts on Risk Adjustment
Understand how more patient diagnoses increase the cumulative risks. Risk adjustment can help providers and [...] - Foster Compliance With These 4 Risk Adjustment Steps
Know which provider types fall into the ‘acceptable’ category. If you’re interested in adding risk [...] - Industry Notes:
Open Payments Data Is Available for Perusal
If you fall into the Covered Recipients’ category of the Centers for Medicare & Medicaid [...] - Industry Notes:
FDA Issues Warning on Misbranded Drugs, Products
The U.S. Food and Drug Administration (FDA) continues to be vigilant about calling out companies [...] - Industry Notes:
Feds Name New COVID Response Coordinator
The White House named Ashish Jha, MD, as the new COVID-19 Response Coordinator on March [...]
View All
